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ABSTRACT: DB1255 is a symmetrical diamidinophenyl-dithiophene
that exhibits cellular activity by binding to DNA and inhibiting binding of
ERG, an ETS family transcription factor that is commonly overexpressed
or translocated in leukemia and prostate cancer [Nhili, R., Peixoto, P.,
Depauw, S., Flajollet, S., Dezitter, X., Munde, M. M., Ismail, M. A.,
Kumar, A., Farahat, A. A., Stephens, C. E., Duterque-Coquillaud, M.,
Wilson, W. D., Boykin, D. W., and David-Cordonnier, M. H. (2013)
Nucleic Acids Res. 41, 125−138]. Because transcription factor inhibition is
complex but is an attractive area for anticancer and antiparasitic drug
development, we have evaluated the DNA interactions of additional
derivatives of DB1255 to gain an improved understanding of the biophysical chemistry of complex function and inhibition.
DNase I footprinting, biosensor surface plasmon resonance, and circular dichroism experiments show that DB1255 has an
unusual and strong monomer binding mode in minor groove sites that contain a single GC base pair ﬂanked by AT base pairs, for
example, 5′-ATGAT-3′. Closely related derivatives, such as compounds with the thiophene replaced with furan or selenophane,
bind very weakly to GC-containing sequences and do not have biological activity. DB1255 is selective for the ATGAT site;
however, a similar sequence, 5′-ATGAC-3′, binds DB1255 more weakly and does not produce a footprint. Molecular docking
studies show that the two thiophene sulfur atoms form strong, bifurcated hydrogen bond-type interactions with the G-N-H
sequence that extends into the minor groove while the amidines form hydrogen bonds to the ﬂanking AT base pairs. The central
dithiophene unit of DB1255 thus forms an excellent, but unexpected, single-GC base pair recognition module in a monomer
minor groove complex.
With our improving understanding of the critical role offunctional control sequences in DNA from projects such
as ENCODE, it is now clear that the opportunities for selective
targeting of speciﬁc and important, but nontranscribed,
sequences of DNA oﬀer exciting options for gene control.1
Such control possibilities have potential in enhancing our
understanding of gene expression mechanisms as well as
therapeutic development that could not be imagined even a
short time ago. The recent evidence that G-quadruplex DNA
could be selectively targeted,2,3 as well as the excellent clinical
anti-infective and anticancer activity of minor groove binding
agents,4 provides encouraging examples of the therapeutic
possibilities in this area. To allow new gene control
mechanisms, it is essential to ﬁnd agents that target a speciﬁc
DNA sequence and exert a desired biological response, such as
inhibition or activation of a critical transcription factor. At the
same time, binding the active compounds to other DNA
sequences should not cause signiﬁcant biological eﬀects in the
same concentration range. Selective activity can be accom-
plished with molecules that are not particularly large, so that
they maintain cell uptake and are reasonable in cost and eﬀort
to synthesize on a large, clinical scale.5−7 While compounds
that meet these requirements are not common, they do exist,
but unfortunately, the rules for their design are essentially
unknown. Emerging information about local DNA micro-
structural states8−10 may help unravel some keys to the
selective biological action of eﬀective DNA-targeting small
molecules.
Initial steps for success in developing agents that function, as
described above, require design and synthesis of new DNA-
binding compounds and evaluating their DNA aﬃnity and
selectivity. A compound that has recently been shown to exhibit
eﬀects quite close to the desired in vivo behavior is dithiophene
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DB1255 (Figure 1).11 The compound targets the DNA binding
of the ERG protein, an ETS transcription factor that is
commonly overexpressed or translocated in leukemia and
prostate carcinoma.12−16 This is a promising ﬁnding because
transcription factors have generally been considered undrug-
gable and direct modulation of gene expression by targeting
oncogenic transcription factors is an exciting new area of
development for cancer treatment. The inhibition of binding of
ERG to DNA was discovered in a screening assay of synthetic
DNA binding compounds and was veriﬁed by electrophoretic
mobility shift assays (EMSAs). Additional EMSA analysis
deﬁned the precise DNA-binding sequence required for optimal
binding of dithiophene DB1255 and thus for eﬃcient inhibition
of the ERG−DNA complex. It is very important that biological
assays conﬁrmed that DB1255 could modulate transcription
factor binding in cells.11 Thus, relatively small molecules can
speciﬁcally target DNA-transcription factor sites, such as the
ERG−DNA recognition site, both in vitro and in cells.
Figure 1. DNA oligomer sequences and compounds used in this study.
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Given the importance of the cellular activity and tran-
scription factor inhibition of DB1255, as well as our lack of
detailed knowledge about the biophysical chemistry of the
interaction of the compound and its derivatives with DNA, the
experiments reported here were initiated. Dithiophene DB1255
is unusual for heterocyclic diamidines that target the DNA
minor groove in that it can bind to GC-containing sequences,
and this is essential for its inhibition of the ERG transcription
factor. It was not clear from the initial studies whether DB1255
binds as a monomer, as with the most similar AT speciﬁc minor
groove binders, or as a dimer as observed with the furan
derivative, DB293, in mixed AT- and GC-containing sequences
(Figure 1). It was also not clear what structural features and
chemical properties of DB1255 are necessary for its recognition
of mixed DNA sequences. To address these key points,
spectroscopy, thermal melting, DNase I footprinting, biosensor
surface plasmon resonance (SPR), and molecular modeling
were used to evaluate the interactions of DB1255 and its
analogues with both pure AT-containing and GC-containing
(Figure 1) DNA sequences. Very surprisingly, we have found
that, unlike DB293 and synthetic polyamides that bind to
mixed DNA sequences as dimers, DB1255 binds to certain GC-
containing sequences in the minor groove as a monomer, and
the binding is very dependent on the dithiophene group.
■ MATERIALS AND METHODS
DNAs, Compounds, and Buﬀers. The syntheses of DB75,
DB832, DB914, DB1255, DB1282, DB1341, DB1450, and
DB1998 (Figure 1) have been previously described,17,18 and the
scheme and experimental details for DB2297 are given in the
Supporting Information. Their purity was veriﬁed by nuclear
magnetic resonance and elemental analysis. Concentrated stock
solutions (1 mM) of compounds were prepared in water.
Solutions of the compounds for biosensor surface plasmon
resonance (SPR) and spectroscopic studies were prepared by
dilution with 0.01 M cacodylic buﬀer (pH 6.25) with 0.001 M
EDTA and 0.1 M NaCl. SPR binding studies were conducted
with 5′-biotinated DNAs as previously described,19,20 while
spectroscopic studies were performed with non-biotin-labeled
DNAs (Figure 1). The concentration of the DNA solutions was
determined spectrophotometrically at 260 nm using extinction
coeﬃcients per nucleotide for 5′-CCATGATTGCTCTCAAT-
CATGG-3′ and 5′-GGAATTCGTCTCCGAATTCC-3′. The
extinction coeﬃcients were calculated by the nearest-neighbor
method.21
DNase I Footprinting. Experiments were performed as
previously described11 using a 265 bp 3′-end-labeled DNA
fragment obtained from EcoRI and PvuII double digestion of
the pBS plasmid (Stratagene, La Jolla, CA) followed by
radiolabeling using [γ-32P]dATP (Perkin-Elmer) and the
Klenow enzyme for 30 min. The 265 bp radiolabeled DNA
fragment was then puriﬁed on a 10% polyacrylamide gel under
native conditions. Increasing concentrations of the various
ligands were incubated with the radiolabeled DNA fragment for
15 min at 37 °C to ensure equilibrium prior to digestion for 3
min upon addition of DNase I (0.01 unit/mL) in 20 mM NaCl,
2 mM MgCl2, and 2 mM MnCl2 (pH 7.3). The DNA samples
were then precipitated, heated at 90 °C for 4 min in loading
denaturing buﬀer, and chilled in ice prior to being loaded on an
8% denaturing polyacrylamide gel for 90 min at 65 W in TBE
buﬀer. The data were collected using a Phosphor Imager and
analyzed using ImageQuant as previously described.11 Each
resolved band was assigned to a particular base of the DNA
fragment by comparison of its position relative to the guanine
sequencing standard (G-track) obtained using DMS/piperidine
treatment of the 265 bp DNA fragment.
Thermal Melting (Tm). Tm experiments were conducted
with a Cary 300 UV−visible spectrophotometer in 1 cm quartz
cuvettes. The absorbance of the DNA−compound complex was
monitored at 260 nm as a function of temperature, and DNA
without the compound was used as a control. Cuvettes were
mounted in a thermal block, and the solution temperatures
were monitored by a thermistor in a reference cuvette with a
computer-controlled heating rate of 0.5 °C/min. Experiments
were generally conducted at a hairpin duplex oligomer
concentration of 3 × 10−6 M. For experiments with complexes,
a ratio of two compounds per oligomer duplex was generally
used.
CD Spectroscopy. A 1 cm path length cell was used, and all
experiments were conducted at 25 °C. The DNA hairpin
duplexes (3 × 10−6 M per hairpin duplex) were titrated with
increasing concentrations of compound. The resulting ratios
increased from 0.25 to 2.0 (moles of compound to moles of
DNA duplex). The experiments were performed in cacodylic
acid buﬀer (pH 6.25). The sensitivity was set at 1 mdeg, and
the scan speed was set at 50 nm/min. Four scans were recorded
and averaged by the computer for each titration point.
Surface Plasmon Resonance (SPR). SPR measurements
were performed with a four-channel Biacore 2000 optical
biosensor system. The 5′-biotin-labeled DNA samples were
immobilized onto streptavidin-coated sensor chips (Biacore
SA) as previously described.19,20 Three ﬂow cells were used to
immobilize the DNA oligomer samples, while a fourth cell was
left blank as a control. The SPR experiments were performed at
25 °C in ﬁltered, degassed, 10 mM cacodylic acid buﬀer (pH
6.25) containing 100 mM NaCl and 1 mM EDTA. Steady-state
binding analysis was performed with multiple injections of
diﬀerent compound concentrations over the immobilized DNA
surface at a ﬂow rate of 25 μL/min and 25 °C. Solutions with
known ligand concentrations were injected through the ﬂow
cells until a constant steady-state response was obtained.
Compound solution ﬂow was then replaced by buﬀer ﬂow,
resulting in dissociation of the complex. The reference response
from the blank cell was subtracted from the response in each
cell containing DNA to give a signal (RU, response units) that
is directly proportional to the amount of bound compound.
The predicted maximal response per bound compound in the
steady-state region (RUmax) was determined from the DNA
molecular weight, the amount of DNA on the ﬂow cell, the
compound molecular weight, and the refractive index gradient
ratio of the compound and DNA, as previously described.22
The reference response from the blank cell was subtracted from
the response in each cell containing DNA to give a signal (RU,
resonance units) that is directly proportional to the amount of
bound compound. The stoichiometry of the reaction can be
calculated as follows:
=
=
r rmoles of bound ligand/moles of DNA or where
RU/RUmax
where RU is the observed (experimental) response in the
plateau region and RUmax is the predicted maximal response for
a single small molecule binding to a nucleic acid site. Dividing
the observed steady-state response RU by RUmax yields a
stoichiometry-normalized binding isotherm. The calculated
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value (r) was ﬁt to an appropriate binding model, either a
single-site model (K2 = 0) or a two-site model:
= = +
+ +
‐ r K C K K C
K C K K C
RU/RU ( 2 )
/(1 2 ...
pred max 1 free 1 2 free
1 free 1 2 free (1)
where K1 and K2 are macroscopic binding constants and Cfree is
the free compound concentration in equilibrium with the
complex (the concentration in the ﬂow solution).20
Molecular Docking. Dithiophene DB1255 and difuran
DB914 were optimized at the B3LYP/6-31G* level of theory
using Spartan 10.23 All minimized ligands were assigned
Gasteiger−Hückel charges by using Autodock version 4.02.24
A DNA duplex sequence of d[(5′-CCATGATCT-3′)(5′-
AGATCATGG-3′)], based on footprinting results, was
generated from the Biopolymer-build DNA double helix from
the Tripos SYBYL-X1.2 software package.25 The modeled
double-stranded DNA (ds-DNA) was then docked with the
optimized ligand using Autodock version 4.02.26
The center of the macromolecule is the grid center with a
grid size of 20 Å × 25 Å × 33 Å and a grid spacing of 0.375 Å.
Docking runs were performed using the Lamarckian genetic
algorithm (LGA) with no modiﬁcations of docking parameters.
LGA was used because of the existence of rotatable bonds in
the ligands and to evaluate the correct conjugate DNA
conformation, as it is known to reproduce various experimental
ligand−DNA complex structures. Initially, we used a population
of random individuals (population size of 150), a maximal
number of 2500000 energy evaluations, a maximal number of
evaluations of 2700, and a mutation rate of 0.02 fs. Fifty
independent ﬂexible docking runs were conducted for each
ligand, and then the lowest-energy dock conformation obtained
from the ﬂexible docking was resubmitted for rigid docking to
remove the internal energy of the ligand (steric clashes) and
retain the hydrogen bonding interaction with ds-DNA bases.
■ RESULTS
DNase I Footprinting. To evaluate the optimal binding
sites for DB1255 and analogues on DNA and to gain insight
into the precise bases that are crucial for DNA complex
formation, a DNase I footprint assay was conducted. The DNA
restriction fragment used is one that has previously been tested
with several heterocyclic diamidines.6 Footprinting gel results
are shown in Figures 2A and 3A−C and Figure S1A of the
Figure 2. DNase I footprinting titration experiments that aimed to examine the binding of DB1255 to DNA. (A) Denaturing polyacrylamide gel of
the 265 bp 3′-end-radiolabeled DNA fragments incubated with the various tested compounds and (B) the corresponding densitometric analysis.
Gray boxes indicate AT-rich tracks of the indicated sequences. Black boxes indicate the ATGA site speciﬁc for DB293 (italic) or speciﬁcally
recognized by DB1255 (bold). G indicates a G-track was performed to localize guanines in the DNA fragment and thus deduce the position of each
base within the known 265 bp sequence.
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Supporting Information, and densitometer traces are shown in
Figures 2B and 3B−D and Figure S1B of the Supporting
Information. The DNA sequence used contains three AT sites
that give strong footprints with AT speciﬁc minor groove
binders: 5′-AAAA-3′ between positions 50 and 60, 5′-
AAATTA-3′ between positions 70 and 80, and 5′-ATTA-3′
between positions 90 and 100. The sequence also has two 5′-
ATGA-3′ sites within diﬀerent contexts (5′-ATGAC-3′ and 5′-
ATGAT-3′) on both sides of position 100, and both bind
DB293 as a dimer. DB1255 behaves in a diﬀerent manner with
strong footprints at only one 5′-ATGA-3′ site (5′-ATGAT-3′
and not 5′-ATGAC-3′) and the 5′-ATTA-3′ site between
positions 90 and 100 (Figure 2). It also has footprints at the
more remote 5′-AAAA-3′ and 5′-AAATTA-3′ sites described
above. The results for the site with a single GC base pair in an
AT sequence agree with the optimal footprinting site observed
around the ERG protein binding site for DB1255, 5′-AAGTT-
3′.11 Clearly, DB1255 has an overall recognition capability
diﬀerent from that of classical AT speciﬁc minor groove binders
or the DB293 dimer at ATGA.
Related derivatives were also evaluated for sequence
selectivity on the same DNA sequence (Figure 3) to establish
structure−binding selectivity relationships. Among the dithio-
phenes, the addition of a methyl group to the phenyls
(DB1357) or the thiophenes (DB1514) and addition of a
ﬂuoro substituent to the phenyls (DB1578) maintain the
binding on the 5′-ATGA-3′ site that is recognized by DB1255
(Figure 2). Similar binding to ATGA also occurs, but to a lesser
extent, when phenyls are replaced with pyridines (DB1247).
However, the ATGA binding speciﬁcity is lost when the two
thiophenes are replaced with two furans (DB914), and related
compounds DB832, DB934, DB1246, DB1324, DB1579,
Figure 3. DNase I footprinting titration experiments with derivatives of DB1255. (A and C) Denaturing polyacrylamide gel and (B and D) the
corresponding densitometric analysis. G, gray, and black boxes are as deﬁned in the legend of Figure 2.
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DB1315, and DB1256, or by two selenophanes (DB1282 and
DB1273 with phenyls or pyridines, respectively). Replacing
dithiophenes in DB1255 with dithiazoles in DB1998 results in a
loss of binding to the 5′-ATGAT-3′ footprint site but retention
of the recognition of its closest AT-rich site at positions 92−95
as well as to the AT-rich sequences around positions 75 and 55
(Figure S1 of the Supporting Information). DB1998 is known
to have nonspeciﬁc binding properties,11 and because the
footprinting ATGA sequence overlaps signiﬁcantly with AT
sites, it does not discriminate between these sites. Therefore,
for other biophysical studies such as Tm, SPR, and CD, we have
used hairpin sequences that do not have overlapping sites to
verify the binding strength of DB1998 and other compounds.
Interestingly, the addition of a second furan ring (DB1256) to
DB293 results in a longer molecule that totally abolishes the
binding to both ATGA sites and strongly reduces the level of
binding to AT-rich sites. Binding could be seen only using 1.5
μM DB1256 (Figure 3A,B) and not lower concentrations
(Figure S1 of the Supporting Information). These results
illustrate that the increased curvature of DB1256 is not optimal
for minor groove binding.
Relative Binding Aﬃnity and Speciﬁcity Determined
by Thermal Melting (Tm). To obtain initial aﬃnity values for
the DNA complexes of diﬀerent compounds, thermal melting
experiments were performed with hairpin oligomer duplexes
containing a pure AT sequence (5′-AATT-3′) and a mixed
sequence (5′-ATGA-3′ in the preferred 5′-ATGAT-3′ context).
The speciﬁc binding sites in each oligomer duplex were based
on DNase I footprinting studies (Figures 2 and 3). The
compounds were added to the target DNAs at 1:1 and 2:1
compound:DNA ratios, and the maximal Tm value is near 1:1
for the strong binding compounds. These results indicate that a
maximum of 1 mol of compound is bound per mole of DNA
sites at saturation. Figure S2 of the Supporting Information
shows representative Tm plots of selected compounds in the
presence of the 5′-ATGA-3′ sequence, and Tm values are listed
in Table S1 of the Supporting Information. Dithiophene
DB1255 binds strongly to the 5′-ATGA-3′ hairpin duplex
(ΔTm = 12.2 °C) compared to furan DB914 (2.1 °C) and
selenophane DB1282 (5.3 °C) derivatives, in agreement with
DNase I footprinting experiments. Dithiazole DB1998 binds to
ATGA strongly with a ΔTm of 14.1 °C but also binds equally
strongly to AATT with a ΔTm of 15.1 °C and thus has poor
sequence selectivity, while dithiophene DB1255 and closely
related compounds bind more weakly to 5′-AATT-3′ (AATT
ΔTm = 7.5 °C). The fused dithiophene, DB2297, shows a low
ΔTm of 1.0 °C with 5′-ATGA-3′, and this indicates its shape
does not match that of the minor groove. From the Tm studies,
it is clear that DB1255 has better DNA sequence selectivity and
stabilizes the ATGA sequence better than other related
compounds (Figure 1).
Binding Modes Determined by Circular Dichroism.
Although these compounds are expected to target the DNA
minor groove, CD studies are important to establish the
binding mode, especially for the ATGA sequence. Strong
positive induced CD signals upon titration of the compound to
DNA sequences are characteristic of binding in the minor
groove of DNA.27 DB1255 showed a strong positive induced
CD (Figure 4A) upon titration into the ATGA sequence. The
CD results as a function of ratio are compared for ATGA in
Figure 4C, and the plots clearly illustrate that DB293 binds at a
2:1 ratio as opposed to DB1255, which exhibits binding site
saturation and CD signal magnitudes characteristic of a 1:1
complex with ATGA. The monomer binding mode is surprising
for a sequence with GC base pairs and is unlike that of DB293
and most polyamides of a similar size.5−7,28 DB1255 also
showed positive induced CD in the presence of AATT, but the
signal is signiﬁcantly weaker than in the presence of ATGA
(not shown). DB1998 also induces strong CD signals when it is
bound to ATGA (Figure 4G), again in agreement with Tm
Figure 4. CD spectra of compounds in ATGA: (A) DB1255, (B) DB293, (D) DB1282, (E) DB1450, (F) DB832, and (G) DB1998. The ratios of
the compound to DNA are given. (C) Plot of the induced CD signal vs the compound to DNA concentration ratio for DB293 and DB1255.
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values. The tricyclic compounds DB1450, DB832, and DB1341
bind very weakly to DNA (Figure 4E,F) and did not induce a
strong signal upon forming a complex with the ATGA
sequence, in agreement with footprint and Tm results.
Binding Aﬃnity, Speciﬁcity, and Stoichiometry
Determined by Biosensor Surface Plasmon Resonance
(SPR). To quantitatively evaluate the DNA aﬃnity and
stoichiometry of DB1255, biosensor SPR experiments were
conducted with immobilized DNA hairpin duplexes containing
ATGA and AATT binding sequences (Figure 1). Because the
SPR approach responds to mass, it is an excellent method for
comparative studies of dications that have very large diﬀerences
in properties and equilibrium binding constants, K. In the initial
studies, it was observed that DB1255 sticks to the injection
needle and tubing of the instrument, and in the beginning
injection time range, the ﬂow solution is depleted of DB1255.
Therefore, the experiments for DB1255 were performed in the
presence of DMSO in samples and running buﬀer. We have
tested such conditions previously and found that the presence
of ≤10% DMSO helped to reduce the loss of compound to
tubes and surfaces in SPR without signiﬁcantly aﬀecting the
binding aﬃnity or the DNA properties on the surface.11 At a
DMSO concentration of 10%, we were able to successfully
obtain SPR sensorgrams of binding of DB1255 to DNA.
SPR sensorgrams (Figure 5) were subjected to steady-state
analyses and then ﬁt to appropriate binding models to
determine K values for all compounds (Materials and
Methods). On the basis of Tm, CD, and footprinting studies,
only four compounds, dithiophene DB1255, diselenophane
DB1282, dithiazole DB1998, and furan DB293, were selected
for SPR binding studies. DB293, which was shown earlier to
bind as a cooperative dimer to ATGA, was used to provide a
reference for the stoichiometry of these complexes.1,5 In Figure
5, the SPR signal for DB1255−ATGA complex formation is
half that produced by DB293 and shows that DB1255 binds as
a monomer compared to the stacked dimer formed by DB293
in the ATGA minor groove. In agreement with the results
produced by other methods, the binding to AATT and ATGA
in SPR was very dependent on compound structure. SPR
results in Figure 6B show that DB1255 binds strongly to ATGA
(KD = 26 nM) compared to AATT (KD = 86 nM). The Se
derivative, DB1282 (Figure 6D and Table 1), binds 15 times
weaker to ATGA than DB1255 with signiﬁcant nonspeciﬁc
interactions. The diﬀerences in binding aﬃnity for these two
compounds that diﬀer only at the central heterocycles are
striking. DB1255 is approaching saturation of the ATGA
binding sites at 0.1 μM, while DB1282 is just beginning to bind
at that point.
Dithiazole analogue DB1998 binds as strongly to ATGA [KD
= 30 nM (Figure 6C)] as dithiophene DB1255 but shows little
Figure 5. Surface plasmon resonance study. Representative sensorgrams of DB293 and DB1255 in the presence of ATGA. The compound
concentration for DB293 ranges from 0.01 to 1 μM and for DB1255 from 0.001 to 0.3 μM (from bottom to top, respectively).
Figure 6. Binding aﬃnity study using SPR. Binding plots for ATGA and AATT for (A) DB293, (B) DB1255, (C) DB1998, and (D) DB1282. The
data were ﬁt to a steady-state binding function using appropriate 1:1 or 2:1 models to determine equilibrium binding constants.
Table 1. Equilibrium Binding Constants for DB1255 and Its
Analogues in the Presence of ATGA and AATTa
KD (nM)
compound ATGA AATT
DB293b 114; 32 45
DB1255 26 86
DB1282 416 1219
DB1998 24 33
aThe experiments were conducted in cacodylic acid buﬀer (pH 6.25)
at 25 °C. bK1 and K2 are the ﬁrst and second equilibrium binding
constants, respectively, obtained from a 2:1 cooperative binding model
for DB293 with ATGA. Other compounds bind to both DNAs as 1:1
complexes. Dissociation constants were calculated from SPR experi-
ments.
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speciﬁcity as it also binds strongly to AATT [KD = 24 nM
(Table 1)]. The thiazole SPR result is diﬀerent from the
footprinting sequence in which no footprint is seen at ATGA
(Figure 3 and Figure S2 of the Supporting Information). The
diﬀerence is likely due to the isolated ATGA site in the DNA
oligomer used in SPR, while there is an AT site almost
overlapping the ATGA site in the footprint sequence. The
strong binding of DB1998 at AT sequences, also observed in
SPR, probably explains the inhibition of its binding to ATGA in
the footprint sequence. The fused ring compound, DB2297,
binds very weakly to ATGA, and the binding constants are not
in the instrument’s range for binding analysis. Interestingly,
sensorgrams for DB293 (Figure 5) and other compounds show
oﬀ rates much faster than those of DB1255. Clearly, the
features of the DB1255 molecule allow it to bind as a monomer
to ATGA with a higher aﬃnity compared to other diamidines,
and with much slower binding kinetics. These binding trends
are supported by the Tm results listed in Table S1 of the
Supporting Information and by DNase I footprinting experi-
ments (Figures 2 and 3 and Figure S1 of the Supporting
Information) for these and other compounds.
■ DISCUSSION
Our previous studies with dithiophene derivative DB1255
showed that the compound could bind to an AT sequence with
one GC base pair11 but provided limited quantitative
information about the complex of DB1255 or its analogues
with mixed base pair sites. Given the excellent transcription
factor inhibition and biological results with DB1255 in cells, we
have undertaken a more detailed biophysical analysis of
DB1255 and some analogue complexes with DNA. The
intrinsically narrow AT DNA minor groove that is recognized
by monomer heterocyclic compounds is a well-established
phenomenon.29,30 Mixed guanine-containing DNA sequences
typically have wider grooves and are, therefore, diﬃcult to
recognize using a monomer complex.8 On the basis of work
with polyamides and heterocyclic diamidines, such as
DB293,5,31 dimer-forming compounds have been used to
enhance speciﬁcity and aﬃnity for wider DNA minor grooves
with GC base pairs. Even after these initial successes, however,
we understand relatively little about the general compound
structural features necessary for mixed DNA recognition by
most heterocyclic cations. Because DB1255 has been found to
bind strongly to a mixed AT and GC sequence in both cellular
and in vitro contexts,11 the compounds of Figure 1 were
evaluated in an eﬀort to understand the compound structural
features necessary to recognize mixed sequences of AT and GC
base pairs in DNA. The compounds (Figure 1) have variable
lengths, symmetries, and ring heteroatoms for testing of their
eﬀects on the mixed sequence of DNA.
In our initial investigation of DNA binding by DB1255, it
was a surprise to ﬁnd that it has a high Tm value, very strong
CD signals with ATGA, and 4-fold better binding aﬃnity for
ATGA versus AATT. Compounds that speciﬁcally recognize
GC base pairs usually have strong H-bond acceptors such as the
furan in DB293. The second major surprise with DB1255 was
that it clearly binds strongly as a monomer, not as a dimer, to
ATGA. SPR results show better speciﬁcity for that sequence
with DB1255 than for the DB293 dimer (Table 1). The results
in this paper, thus, clearly show that DB1255 has a novel GC
recognition mode and is able to induce narrowing in the minor
groove width of GC-containing sequences for optimal
interactions.
To evaluate ideas for how DB1255 is able to eﬀectively bind
to the ATGA sequence, a molecular docking study was
conducted with the duplex d[(5′-CCATGATCT-3′)(5′-AGA-
TCATGG-3′)].26 The molecule was docked into the 5′-
cATGAt-3′ sequence, found in footprinting and used in the
other experiments, and energy minimized. The low-energy
form (Figure 7) has bifurcated H-bond-type interactions from
the G-NH2 group, which projects into the minor groove, to the
two thiophene S atoms that are symmetrically located on both
sides of the G-NH2 group. The G-NH2 group−S distances are
2.3 and 2.2 Å (Figure 7). One amidine (the bottom one in
Figure 7) forms an H-bond with a thymine (T) carbonyl group
on the complementary strand. The other amidine (the top one
in Figure 7) is adjacent to the ﬂanking 3′-T in cATGAt, so that
the actual binding site is 5 bp and should be written as 5′-
ATGAT-3′. This latter amidine can alternately form H-bonds
with the thymine carbonyl (weaker in this calculation) or to an
adjacent backbone deoxyribose O (stronger). Interaction with
the 3′-T can explain why DB1255 binds more strongly to 5′-
ATGAT-3′ than to 5′-ATGAC-3′, which has the 3′-terminal
GC base pair H-bond in the minor groove. DB293 binds well to
Figure 7. Docking of DB1255 to d[(5′-CCATGATCT-3′)(5′-
AGATCATGG-3′)] by using Autodock version 4.02. Two thiophene
S atoms (yellow) form bifurcated hydrogen bonds with the G-NH in
the minor groove (shown with a yellow dashed line). The lower
amidine group forms H-bonds with the thymine (T) carbonyl of T4,
which is at the 5′ side of G on the opposite strand), and to a
deoxyribose oxygen of the DNA backbone (yellow dashed lines) on
the same strand as G. The top amidine group is adjacent to the
ﬂanking 3′-T in cATGAt and forms an H-bond with the DNA
backbone (yellow dashed line). The DNA backbone is shown as a stick
model, colored by atom type (gray for carbon, red for oxygen, blue for
nitrogen, and orange for phosphorus). The G5 base is displayed as a
ball and stick and colored by atom type (cyan for carbon, white for
hydrogen, and blue for nitrogen), and the ligand is displayed as a ball
and stick also and colored by atom type (magenta for carbon, white for
hydrogen, and blue for nitrogen).
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both sequences, but DB1255 binds to only 5′-ATGAT-3′. The
thiophenes have the best shape to give the optimal minor
groove binding conformation to DB1255 with the thiophenes
and terminal amidines in position to strongly recognize the
ATGAT sequence.
A similar modeling study was conducted with DB914, the
difuran analogue of DB1255, which does not have signiﬁcant
binding with the ATGA sequence. No satisfactory minor
groove-bound conformation could be found for DB914 (Figure
S3 of the Supporting Information). The difuran system is
signiﬁcantly more curved than the dithiophene of DB1255, and
as a result, the difuran is pushed away from the ﬂoor of the
minor groove and only the amidines interact with the bases.
Frequently, a more linear conformation was observed with one
furan O pointed into the groove and one pointed out, but all of
the observed DNA complexes have a higher energy than the
DB1255 complex. A second relatively low-energy model for
DB1255 was also found in the modeling experiments (Figure
S4 of the Supporting Information) but with a frequency
signiﬁcantly lower than that of the structure in Figure 7. The
higher-energy model has a single thiophene S−G NH group
interaction such that DB1255 can slide back and forth ﬁrst to
have one thiophene and then the other interacting with the G
NH group. It seems likely that the single-interaction models are
in a dynamic minor groove equilibrium with the structure that
has two interactions. The low-energy structure probably serves
as a bridge between the two single-interaction conformations.
Dithiazole DB1998 binds to ATGA in the isolated sequence
in SPR and CD but does not bind to it in the more complex
footprinting sequence. The compound also failed to show
speciﬁcity in SPR as it binds equally strongly to pure AT
sequences (Table 1). Such a strong propensity to interact at an
AT-rich site may have oriented the binding of DB1998 to the
AT-rich site adjacent to the ATGA site rather than to the
ATGA site in the footprinting experiments. This is a very
important observation because in our recent ﬁndings,11 it was
concluded that DB1255 has better biological activity than
DB1998. DB1255 recognizes mixed sequence DNA strongly
and speciﬁcally to inhibit DNA binding by the ERG
transcription factor and is an excellent lead compound for
anticancer therapeutic development.11 DB2297, the fused ring
analogue of DB1255, binds very weakly to ATGA. The
presence of fused thiophenes changes the structure and
properties of DB2297 completely, giving it a more linear
shape, which in this case is not appropriate for minor groove
binding. This compound modiﬁcation shows that the presence
of two thiophenes is not suﬃcient for strong binding if the
shape of the compound is not optimal for the ATGA groove.
The shorter dithiophene, DB1450, showed nonspeciﬁc binding
to ATGA via SPR and is not comparable to DB1255. The loss
of a phenyl in DB1450 and the nonoptimal radius of curvature
cause poor binding of that compound. In DB1341, the presence
of three thiophenes did not help to improve the DNA binding
aﬃnity for ATGA. In conclusion, these results show that in
DB1255 the two thiophenes are essential in making key
contacts with the G NH group, and the two terminal
phenylamidine modules play an extremely important role in
the ﬁt of the compound into the ATGAT minor groove. When
this structure is signiﬁcantly modiﬁed, for example, in the
difuran and diselenophane compounds, the aﬃnity for ATGA
decreases dramatically.
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